$PULM
Pulmatrix Inc

2017 Q1 Form 10-K Financial Statement

#000119312517077912 Filed on March 10, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2015 Q4 2015
Revenue $0.00 $280.0K $1.201M
YoY Change -100.0% 241.19%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.640M $2.100M $4.530M
YoY Change -31.95% 91.43% 160.94%
% of Gross Profit
Research & Development $1.672M $2.470M $7.187M
YoY Change -51.25% 299.03% 9.06%
% of Gross Profit
Depreciation & Amortization $64.00K $50.00K $232.0K
YoY Change 10.34% -32.16%
% of Gross Profit
Operating Expenses $3.312M $4.570M $24.22M
YoY Change -43.28% 166.32% 156.88%
Operating Profit -$3.312M -$23.02M
YoY Change -39.15% 153.61%
Interest Expense $187.0K -$220.0K $953.0K
YoY Change -16.14% -93.76%
% of Operating Profit
Other Income/Expense, Net $16.00K -$20.00K -$44.00K
YoY Change -633.33% -600.0% 1366.67%
Pretax Income -$3.480M -$4.540M -$26.17M
YoY Change -38.62% 165.5% 291.14%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$3.483M -$4.540M -$26.17M
YoY Change -38.56% 165.19% 8.38%
Net Earnings / Revenue -1621.43% -2178.77%
Basic Earnings Per Share
Diluted Earnings Per Share -$2.071M -$3.068M -$32.31M
COMMON SHARES
Basic Shares Outstanding 17.83M shares 14.52M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q1 2015 Q4 2015
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.54M $18.90M $18.90M
YoY Change -28.54% 63.35% 82.43%
Cash & Equivalents $10.54M $18.90M $18.90M
Short-Term Investments
Other Short-Term Assets $410.0K $206.0K $1.560M
YoY Change 99.03% 312.0% 875.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $10.95M $20.46M $20.46M
YoY Change -30.51% 2362.33% 94.49%
LONG-TERM ASSETS
Property, Plant & Equipment $722.0K $685.0K $690.0K
YoY Change -7.79% 45.74% 331.25%
Goodwill $10.91M $15.94M
YoY Change -31.54%
Intangibles $7.534M
YoY Change
Long-Term Investments
YoY Change
Other Assets $200.0K $250.0K $250.0K
YoY Change 0.0%
Total Long-Term Assets $11.84M $24.41M $24.41M
YoY Change -51.59% 3290.42% 15156.25%
TOTAL ASSETS
Total Short-Term Assets $10.95M $20.46M $20.46M
Total Long-Term Assets $11.84M $24.41M $24.41M
Total Assets $22.79M $44.87M $44.87M
YoY Change -43.33% 2793.17% 320.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $235.0K $1.090M $1.090M
YoY Change -81.53% 404.63%
Accrued Expenses $1.439M $1.486M $1.490M
YoY Change 35.75% -58.07% 132.81%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.661M $1.029M $1.030M
YoY Change 58.2%
Total Short-Term Liabilities $4.335M $3.605M $3.610M
YoY Change 8.0% -91.71% 464.06%
LONG-TERM LIABILITIES
Long-Term Debt $2.522M $5.692M $5.690M
YoY Change -50.25%
Other Long-Term Liabilities $40.00K $10.00K $10.00K
YoY Change 300.0%
Total Long-Term Liabilities $2.522M $5.692M $5.700M
YoY Change -50.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.335M $3.605M $3.610M
Total Long-Term Liabilities $2.522M $5.692M $5.700M
Total Liabilities $6.892M $12.27M $12.27M
YoY Change -42.82% -72.6% 1817.19%
SHAREHOLDERS EQUITY
Retained Earnings -$159.4M -$128.1M
YoY Change 19.18% 25.67%
Common Stock $175.3M $160.7M
YoY Change 8.27% 594.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.90M $32.61M $32.61M
YoY Change
Total Liabilities & Shareholders Equity $22.79M $44.87M $44.87M
YoY Change -43.33% 2793.17% 320.13%

Cashflow Statement

Concept 2017 Q1 2015 Q4 2015
OPERATING ACTIVITIES
Net Income -$3.483M -$4.540M -$26.17M
YoY Change -38.56% 165.19% 8.38%
Depreciation, Depletion And Amortization $64.00K $50.00K $232.0K
YoY Change 10.34% -32.16%
Cash From Operating Activities -$2.990M -$2.980M -$12.47M
YoY Change -26.72% 127.48% 131.35%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$150.0K $266.0K
YoY Change -100.0% -6.67%
Acquisitions
YoY Change
Other Investing Activities $0.00 $9.670M
YoY Change
Cash From Investing Activities $0.00 -$140.0K $9.410M
YoY Change -100.0% -5981.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $9.702M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.350M 0.000 21.52M
YoY Change 6421.21%
NET CHANGE
Cash From Operating Activities -2.990M -2.980M -12.47M
Cash From Investing Activities 0.000 -140.0K 9.410M
Cash From Financing Activities 9.350M 0.000 21.52M
Net Change In Cash 6.360M -3.120M 18.46M
YoY Change -253.25% 138.17% -453.64%
FREE CASH FLOW
Cash From Operating Activities -$2.990M -$2.980M -$12.47M
Capital Expenditures $0.00 -$150.0K $266.0K
Free Cash Flow -$2.990M -$2.830M -$12.74M
YoY Change -28.0% 116.03% 124.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17830679 shares
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q2 dei Entity Public Float
EntityPublicFloat
29060912
CY2014Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
18000
CY2014Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
39703000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
451000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-78794000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1026000
CY2015Q1 us-gaap Bridge Loan
BridgeLoan
350000
CY2015Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
11000
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
248000
CY2015Q4 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
50000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2605000
CY2015Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
6721000
CY2015Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
2958000
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14745754 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14745754 shares
CY2015Q4 us-gaap Assets
Assets
44873000
CY2015Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
43000
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1937000
CY2015Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
45000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
20462000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
233500000 shares
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
160708000
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2271000
CY2015Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2958000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18902000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2015Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
598000
CY2015Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
4000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1090000
CY2015Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
673000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
43783000
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
2959000
CY2015Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
481000
CY2015Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
2959000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1486000
CY2015Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
38179000
CY2015Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
92000
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5692000
CY2015Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
43783000
CY2015Q4 us-gaap Prepaid Insurance
PrepaidInsurance
220000
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1029000
CY2015Q4 pulm Stock And Warrant Issued During Period Value New Issues
StockAndWarrantIssuedDuringPeriodValueNewIssues
10000000
CY2015Q4 pulm Debt Instrument Unamortized Discount Increase From Additional Issuance During Period
DebtInstrumentUnamortizedDiscountIncreaseFromAdditionalIssuanceDuringPeriod
1847000
CY2015Q4 pulm Prepaid Clinical Trials
PrepaidClinicalTrials
169000
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7534000
CY2015Q4 us-gaap Liabilities
Liabilities
12267000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44873000
CY2015Q4 us-gaap Goodwill
Goodwill
15942000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3605000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
25000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1403000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
685000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3290000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
32606000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.59
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1086000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-128103000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1560000
CY2015Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
31000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
250000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2316569 shares
CY2015Q4 pulm Debt Instrument Accretion Of Debt Discount
DebtInstrumentAccretionOfDebtDiscount
1617000
CY2015Q4 pulm Deferred Tax Assets Deferred Expense Capitalized Startup
DeferredTaxAssetsDeferredExpenseCapitalizedStartup
1396000
CY2015Q4 pulm Accrued Clinical And Consulting Current
AccruedClinicalAndConsultingCurrent
622000
CY2015Q4 pulm Debt Discount Debt Issuance Costs Bridge Loan And Carrying Value Of Term Loan
DebtDiscountDebtIssuanceCostsBridgeLoanAndCarryingValueOfTermLoan
9610000
CY2015Q4 pulm Debt Instrument Convertible Conversion Percentage
DebtInstrumentConvertibleConversionPercentage
1.00 pure
CY2015Q4 pulm Accrued Legal And Patent Current
AccruedLegalAndPatentCurrent
62000
CY2015Q4 pulm End Of Term Fee
EndOfTermFee
55000
CY2015Q4 pulm Debt Instrument Accretion Of Debt Discount And Issuance Costs
DebtInstrumentAccretionOfDebtDiscountAndIssuanceCosts
1629000
CY2016Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
35000
CY2016Q4 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
350000
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
136000
CY2016Q4 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
51000
CY2016Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Noncurrent
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
2959000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
68622000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2671000
CY2016Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
5803000
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14850526 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14850526 shares
CY2016Q4 us-gaap Assets
Assets
16663000
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2862000
CY2016Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
54000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
4759000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q4 us-gaap Liabilities
Liabilities
7902000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16663000
CY2016Q4 us-gaap Goodwill
Goodwill
10914000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4650000
CY2016Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
50031000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
117151000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
50031000
CY2016Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
206000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1317000
CY2016Q4 pulm Deferred Tax Assets Deferred Expense Capitalized Startup
DeferredTaxAssetsDeferredExpenseCapitalizedStartup
1221000
CY2016Q4 pulm Accrued Clinical And Consulting Current
AccruedClinicalAndConsultingCurrent
202000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2660000
CY2016Q4 us-gaap Prepaid Insurance
PrepaidInsurance
197000
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2586000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
632000
CY2016Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
43455000
CY2016Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
58000
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3217000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
698000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
164706000
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2493000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4182000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2016Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
107000
CY2016Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
7534000
CY2016Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
46000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
747000
CY2016Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
796000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
13000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
676000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
654000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
786000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3457000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.82
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
8761000
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
5571000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.89
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1299157 shares
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1172000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-155946000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
577000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
644054 shares
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2016Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
15000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2770405 shares
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
204000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
6.84
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2829301 shares
CY2016Q4 pulm Prepaid Clinical Trials
PrepaidClinicalTrials
9000
CY2016Q4 pulm Debt Instrument Accretion Of Debt Discount
DebtInstrumentAccretionOfDebtDiscount
112000
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.23
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.038 pure
CY2015 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
198000
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.278 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.006 pure
CY2015 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1201000
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17032000
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
232000
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
232000
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.009 pure
CY2016Q4 pulm Debt Discount Debt Issuance Costs Bridge Loan And Carrying Value Of Term Loan
DebtDiscountDebtIssuanceCostsBridgeLoanAndCarryingValueOfTermLoan
1046000
CY2016Q4 pulm Accrued Legal And Patent Current
AccruedLegalAndPatentCurrent
51000
CY2016Q4 pulm End Of Term Fee
EndOfTermFee
155000
CY2016Q4 pulm Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill After Revaluation
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAfterRevaluation
0
CY2016Q4 pulm Debt Instrument Accretion Of Debt Discount And Issuance Costs
DebtInstrumentAccretionOfDebtDiscountAndIssuanceCosts
128000
CY2015Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.4 pure
CY2015Q4 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2016-12-31
CY2015Q4 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2020-12-31
CY2015Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-2692000
CY2015 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
66000
CY2015 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-2291000
CY2015 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
12000
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5795942 shares
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2480000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
18451000
CY2015 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
9671000
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2015 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-19093000
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1309000
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2015 us-gaap Revenues
Revenues
1201000
CY2015 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
4457000
CY2015 us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
20750000
CY2015 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
6910000
CY2015 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
4248000
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-44000
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1185000
CY2015 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
23772000
CY2015 us-gaap Operating Expenses
OperatingExpenses
24219000
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
151000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
5508000
CY2015 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
30422000
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8089925 shares
CY2015 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
37000
CY2015 pulm Cash Restricted For Letter Of Credit
CashRestrictedForLetterOfCredit
200000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-26167000
CY2015 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
3022000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26167000
CY2015 us-gaap Interest Expense
InterestExpense
953000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
9405000
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
806000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1107000
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-26167000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-23018000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
21518000
CY2015 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-13000
CY2015 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
3028000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-12472000
CY2015 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
15943000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
266000
CY2015 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
4500000
CY2015 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
4248000
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y5M16D
CY2015 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
35573000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
60000
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
151000
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7187000
CY2015 pulm Conversion Of Bridge Notes Into Common Stock
ConversionOfBridgeNotesIntoCommonStock
8407000
CY2015 pulm Effective Income Tax Rate Reconciliation Nondeductible Expense Permanent Differences
EffectiveIncomeTaxRateReconciliationNondeductibleExpensePermanentDifferences
0.028 pure
CY2015 pulm Conversion Of Convertible Notes And Accrued Interest Into Common Stock
ConversionOfConvertibleNotesAndAccruedInterestIntoCommonStock
43060000
CY2015 pulm Gain Loss On Conversion Of Convertible Notes
GainLossOnConversionOfConvertibleNotes
-1170000
CY2015 pulm Fair Value Adjustment On Derivative Liability
FairValueAdjustmentOnDerivativeLiability
2291000
CY2015 pulm Effective Income Tax Rate Reconciliation Nondeductible Expense Merger Transaction Costs
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMergerTransactionCosts
0.034 pure
CY2015 pulm Noncash Interest Expenses
NoncashInterestExpenses
613000
CY2015 pulm Fair Value Of Warrant Derivative Liabilities At Issuance Recorded As Debt Discount
FairValueOfWarrantDerivativeLiabilitiesAtIssuanceRecordedAsDebtDiscount
11000
CY2015 pulm Noncash Rent Expense
NoncashRentExpense
-21000
CY2015 pulm Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
10000000
CY2015 pulm Effective Income Tax Rate Reconciliation Nondeductible Expense Interest
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterest
0.035 pure
CY2015 pulm Effective Income Tax Rate Reconciliation Writedown Of Intangible Asset
EffectiveIncomeTaxRateReconciliationWritedownOfIntangibleAsset
0.000 pure
CY2016 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
16000
CY2016 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-24000
CY2016 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
16000
CY2016 dei Entity Registrant Name
EntityRegistrantName
Pulmatrix, Inc.
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6204179 shares
CY2016 dei Document Type
DocumentType
10-K
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0001574235
CY2016 us-gaap Depreciation And Amortization Discontinued Operations
DepreciationAndAmortizationDiscontinuedOperations
184000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2827000
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-14720000
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.88
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.043 pure
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8015000
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.202 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.007 pure
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2356000
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-603000
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Concentrations of Credit Risk</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Cash is a financial instrument that potentially subjects the Company to concentrations of credit risk. For all periods presented, substantially all of the Company&#x2019;s cash was deposited in an account at a single financial institution that management believes is creditworthy. The Company is exposed to credit risk in the event of default by these financial institutions for amounts in excess of the Federal Deposit Insurance Corporation insured limits. The Company maintains its cash at a high quality financial institution and has not incurred any losses to date.</p> </div>
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
250000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
250000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-24866000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1046000
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-82000
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.030 pure
CY2016 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2959000
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2016 us-gaap Revenues
Revenues
835000
CY2016 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
-46000
CY2016 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
-1046000
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.096 pure
CY2016 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M18D
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-312000
CY2016 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1171000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2959000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-13243000
CY2016 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
5029000
CY2016 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
7534000
CY2016 us-gaap Operating Expenses
OperatingExpenses
25701000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-27843000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30802000
CY2016 us-gaap Interest Expense
InterestExpense
881000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-431000
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-346000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-983000
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-27843000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
455000
CY2016 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
24000
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
277 shares
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> In preparing consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Due to inherent uncertainty involved in making estimates, actual results may differ from these estimates. On an ongoing basis, the Company evaluates its estimates and assumptions. These estimates and assumptions include valuing equity securities in share-based payments, estimating fair value of equity instruments recorded as derivative liabilities, estimating the fair value of net assets acquired in business combinations, estimating the useful lives of depreciable and amortizable assets, valuation allowance against deferred tax assets, goodwill impairment, and estimating the fair value of long-lived assets to assess whether impairment charges may apply.</p> </div>
CY2016 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-2.5 reverse stock split
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M6D
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10152000
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.79
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y8M23D
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
86000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
251841 shares
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.71
CY2016 dei Trading Symbol
TradingSymbol
PULM
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
764850 shares
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
3998000
CY2016 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
2000
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14815230 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
10.04
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y9M29D
CY2016 pulm Operating Lease Agreement Amended Date
OperatingLeaseAgreementAmendedDate
2015-10-27
CY2016 pulm Cash Restricted For Letter Of Credit
CashRestrictedForLetterOfCredit
153000
CY2016 pulm Impairment Of Intangible Assets Excluding Goodwill After Tax
ImpairmentOfIntangibleAssetsExcludingGoodwillAfterTax
4575000
CY2016 pulm Increase In Deferred Tax Assets Valuation Allowance
IncreaseInDeferredTaxAssetsValuationAllowance
6248000
CY2016 pulm Effective Income Tax Rate Reconciliation Nondeductible Expense Permanent Differences
EffectiveIncomeTaxRateReconciliationNondeductibleExpensePermanentDifferences
0.005 pure
CY2016 pulm Deferred Tax Assets Tax Credit Carryforwards Expiration Date Description
DeferredTaxAssetsTaxCreditCarryforwardsExpirationDateDescription
Various dates from 2022 through 2036.
CY2016 pulm Intrinsic Value Of Common Stock Warrants Outstanding
IntrinsicValueOfCommonStockWarrantsOutstanding
0
CY2016 pulm Operating Loss Carryforwards Expiration Date Description
OperatingLossCarryforwardsExpirationDateDescription
Various dates from 2023 through 2036.
CY2016 pulm Noncash Or Part Noncash Acquisition Fixed Assets Acquired Trade In Value
NoncashOrPartNoncashAcquisitionFixedAssetsAcquiredTradeInValue
60000
CY2016 pulm Fair Value Adjustment On Derivative Liability
FairValueAdjustmentOnDerivativeLiability
24000
CY2016 pulm Effective Income Tax Rate Reconciliation Nondeductible Expense Merger Transaction Costs
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMergerTransactionCosts
0.000 pure
CY2016 pulm Noncash Interest Expenses
NoncashInterestExpenses
212000
CY2016 pulm Fair Value Of Warrant Derivative Liabilities At Issuance Recorded As Debt Discount
FairValueOfWarrantDerivativeLiabilitiesAtIssuanceRecordedAsDebtDiscount
35000
CY2016 pulm Noncash Rent Expense
NoncashRentExpense
43000
CY2016 pulm Effective Income Tax Rate Reconciliation Nondeductible Expense Interest
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterest
0.001 pure
CY2016 pulm Effective Income Tax Rate Reconciliation Writedown Of Intangible Asset
EffectiveIncomeTaxRateReconciliationWritedownOfIntangibleAsset
0.056 pure

Files In Submission

Name View Source Status
0001193125-17-077912-index-headers.html Edgar Link pending
0001193125-17-077912-index.html Edgar Link pending
0001193125-17-077912.txt Edgar Link pending
0001193125-17-077912-xbrl.zip Edgar Link pending
d310831d10k.htm Edgar Link pending
d310831dex211.htm Edgar Link pending
d310831dex231.htm Edgar Link pending
d310831dex311.htm Edgar Link pending
d310831dex312.htm Edgar Link pending
d310831dex321.htm Edgar Link pending
d310831dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pulm-20161231.xml Edgar Link completed
pulm-20161231.xsd Edgar Link pending
pulm-20161231_cal.xml Edgar Link unprocessable
pulm-20161231_def.xml Edgar Link unprocessable
pulm-20161231_lab.xml Edgar Link unprocessable
pulm-20161231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending